Publications by authors named "L Trasobares-Marugan"
Background: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities.
Material And Methods: Cross-sectional study conducted in April and May, 2023.
Background: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities.
Material And Methods: Cross-sectional study conducted in April and May, 2023.
Article Synopsis
- Apremilast is an oral medication used to treat psoriasis, psoriatic arthritis, and oral ulcers in Behçet's disease, with a study analyzing its use among 41 patients in relation to biological treatments.
- The majority of patients (85.4%) took apremilast for psoriasis, often due to inadequate results from previous treatments, and the medication's continuation wasn't significantly affected by prior biologic use.
- The main reason for stopping apremilast was lack of effective disease control (60.0%), with many patients transitioning to biologic therapies thereafter.